Search Results - "CENTORRINO, F"

Comorbid substance-use in schizophrenia: Relation to positive and negative symptoms by Talamo, A., Centorrino, F., Tondo, L., Dimitri, A., Hennen, J., Baldessarini, R.J.

“…As substance use disorders (SUD) are common in schizophrenia patients, we tested the hypothesis that comorbid patients (SUD[+]) have more positive vs. negative…”
Get full text

Weight loss in overweight patients maintained on atypical antipsychotic agents by CENTORRINO, F, WURTMAN, J. J, BALDESSARINI, R. J, DUCA, K. A, FELLMAN, V. H, FOGARTY, K. V, BERRY, J. M, GUAY, D. M, ROMELING, M, KIDWELL, J, CINCOTTA, S. L

“…Weight gain and associated medical morbidity offset the reduction of extrapyramidal side effects associated with atypical antipsychotics. Efforts to control…”
Get full text

Characteristics and clinical changes during hospitalization in bipolar and psychotic disorder patients with versus without substance-use disorders by Vincenti, A, Ventriglio, A, Baldessarini, R J, Talamo, A, Fitzmaurice, G, Centorrino, F

“…Co-morbid substance-use disorders (SUDs) are prevalent among patients with severe psychiatric disorders, but the characteristics of such patients remain…”
Get more information

Factors Associated With Noncompliance With Psychiatric Outpatient Visits by Centorrino, Franca, Hernán, Miguel A., Drago-Ferrante, Giuseppa, Rendall, Melanie, Apicella, Anthony, Längar, Gabriela, Baldessarini, Ross J.

“…Adherence to recommended services is essential for long-term effectiveness of ambulatory treatment programs, but factors associated with such adherence are not…”
Get full text

Polymorphisms of the dopamine D 4 receptor and response to antipsychotic drugs by Cohen, B. M., Ennulat, D. J., Centorrino, F., Matthysse, S., Konieczna, H., Chu, H.-M., Cherkerzian, S.

Get full text

Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs by COHEN, B. M, ENNULAT, D. J, CENTORRINO, F, MATTHYSSE, S, KONIECZNA, H, CHU, H.-M, CHERKERZIAN, S

“…The dopamine D4 receptor may be a site through which the clinical effects of antipsychotic drugs are mediated. Polymorphisms of a 48 base pair repeat in the…”
Get full text

Pilot Comparison of Extended-Release and Standard Preparations of Divalproex Sodium in Patients With Bipolar and Schizoaffective Disorders by Centorrino, Franca, Kelleher, James P., Berry, Judith M., Salvatore, Paola, Eakin, Marion, Fogarty, Kate V., Fellman, Veronica, Baldessarini, Ross J.

“…OBJECTIVE: The authors compared the new extended-release and standard preparations of divalproex sodium. METHOD: Twelve patients with DSM-IV bipolar disorder…”
Get full text

Oxcarbazepine: clinical experience with hospitalized psychiatric patients by Centorrino, Franca, Albert, Matthew J, Berry, Judith M, Kelleher, James P, Fellman, Veronica, Line, Gyorgy, Koukopoulos, Alexia E, Kidwell, Jennifer E, Fogarty, Kate V, Baldessarini, Ross J

“…Background: Oxcarbazepine (10‐keto‐carbamazepine) appears to be better tolerated and simpler to use than carbamazepine. It has antimanic effects but, as its…”
Get full text

Concurrent use of clozapine and valproate in affective and psychotic disorders by KANDO, J. C, TOHEN, M, CASTILLO, J, CENTORRINO, F

“…This pharmaco-epidemiologic study was undertaken to determine if the combination of clozapine and valproate poses an increased risk of blood dyscrasias, liver…”
Get full text

Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression by Tohen, Mauricio, Vieta, Eduard, Calabrese, Joseph, Ketter, Terence A, Sachs, Gary, Bowden, Charles, Mitchell, Philip B, Centorrino, Franca, Risser, Richard, Baker, Robert W, Evans, Angela R, Beymer, Karin, Dubé, Sanjay, Tollefson, Gary D, Breier, Alan

“…BACKGROUND Despite the longer duration of the depressive phase in bipolar disorder and the frequent clinical use of antidepressants combined with…”
Get full text

Clinically significant interactions of psychotropic agents with antipsychotic drugs by MEYER, M. C, BALDESSARINI, R. J, GOFF, D. C, CENTORRINO, F

“…Various psychotropic drugs are commonly combined with antipsychotic agents. Such combinations can induce pharmacodynamically based, presumably additive,…”
Get full text

Lithium treatment reduces suicide risk in recurrent major depressive disorder by GUZZETTA, Francesca, TONDO, Leonardo, CENTORRINO, Franca, BALDESSARINI, Ross J

“…Evidence that clinical treatment reduces suicide risk in major depressive disorder (MDD) is limited and inconsistent. Since lithium shows major antisuicidal…”
Get full text

Bladder dysfunction associated with clozapine therapy by Frankenburg, F R, Kando, J C, Centorrino, F, Gilbert, J M

Get full text

Multiple Versus Single Antipsychotic Agents for Hospitalized Psychiatric Patients: Case-Control Study of Risks Versus Benefits by Centorrino, Franca, Goren, Jessica L., Hennen, John, Salvatore, Paola, Kelleher, James P., Baldessarini, Ross J.

“…OBJECTIVE: Since use of multiple drugs to treat psychiatric patients is increasing, and research on this practice is rare, the authors carried out a…”
Get full text

Leukopenia associated with addition of paroxetine to clozapine by George, T P, Innamorato, L, Sernyak, M J, Baldessarini, R J, Centorrino, F

Get full text

Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group by Tohen, M, Sanger, T M, McElroy, S L, Tollefson, G D, Chengappa, K N, Daniel, D G, Petty, F, Centorrino, F, Wang, R, Grundy, S L, Greaney, M G, Jacobs, T G, David, S R, Toma, V

“…The primary intent of this study was to compare the efficacy and safety of olanzapine and placebo in the treatment of acute mania. The design involved a…”
Get full text

Health and Economic Burden of Metabolic Comorbidity Among Individuals With Bipolar Disorder by CENTORRINO, Franca, MARK, Tami L, TALAMO, Alessandra, OH, Kelly, CHANG, Jane

“…To compare the prevalence and health care costs of metabolic conditions in patients with bipolar disorder to age- and sex-matched control patients using a…”
Get full text

Olanzapine Versus Placebo in the Treatment of Acute Mania by Tohen, Mauricio, Sanger, Todd M., McElroy, Susan L., Tollefson, Gary D., Chengappa, K.N. Roy, Daniel, David G., Petty, Frederick, Centorrino, Franca, Wang, Richard, Grundy, Starr L., Greaney, Michael G., Jacobs, Thomas G., David, Stacy R., Toma, Verna, The Olanzapine HGEH Study Group

“…OBJECTIVE: The primary intent of this study was to compare the efficacy and safety of olanzapine and placebo in the treatment of acute mania. METHOD: The…”
Get full text

EEG Abnormalities During Treatment With Typical and Atypical Antipsychotics by Centorrino, Franca, Price, Bruce H., Tuttle, Margaret, Bahk, Won-Myong, Hennen, John, Albert, Matthew J., Baldessarini, Ross J.

“…OBJECTIVE: Clozapine produces EEG abnormalities and dose-dependent risk of epileptic seizures. Much less is known about EEG effects of newer antipsychotics…”
Get full text

Inpatient Antipsychotic Drug Use in 1998, 1993, and 1989 by Centorrino, Franca, Eakin, Marion, Bahk, Won-Myong, Kelleher, James P., Goren, Jessica, Salvatore, Paola, Egli, Samy, Baldessarini, Ross J.

“…OBJECTIVE: Patterns of clinical use of antipsychotic agents have changed greatly in the past decade. The authors' goal was to examine these patterns. METHOD:…”
Get full text